Former Medilink member, Birmingham-based Linear Diagnostics Ltd has secured £800,000 from the Midlands Engine Investment Fund (MEIF) and other investors in the company’s second round of funding, which will enable the company to commence the development of the hardware platform for its tests. The finance will facilitate the ongoing development of the company’s high-speed platform technology for point of […]
University of Birmingham researchers have invented a COVID-19 test that reduces testing time from 30 minutes to under five, and delivers accurate results. The method is described in a preprint paper (yet to be peer-reviewed) published on MedRxiv, where the researchers also demonstrate the rapidity and sensitivity of their method using patient sample RNA provided by […]
Scientists at the University of Birmingham have developed a new sensor to measure weak magnetic signals in the brain, which has the potential to increase understanding of connectivity in the brain, and detect signs of traumatic brain injury, dementia and schizophrenia. Magnetic signals in the brain are measured by magnetoencephalography (MEG). They are easier to […]
A new approach to treating cancers and other diseases that uses a mechanically interlocked molecule as a ‘magic bullet’ has been designed by researchers at the University of Birmingham. Called rotaxanes, the molecules are tiny nanoscale structures that resemble a dumbbell with a ring trapped around the central post. Scientists have been experimenting with rotaxanes […]
A nasal spray that can provide effective protection against the COVID-19 virus has been developed by researchers at the University of Birmingham, using materials already cleared for use in humans. A team in the University’s Healthcare Technologies Institute formulated the spray using compounds already widely approved by regulatory bodies in the UK, Europe and the […]
A new spray for treating severely painful blisters, mouth ulceration and oral scarring in patients with a rare genetic skin condition is being developed by researchers at the University of Birmingham. The spray is designed for patients with Epidermolysis Bullosa (EB), a condition that causes the skin to blister and tear at the slightest touch. […]
A method for detecting traumatic brain injury at the point of care has been developed by scientists at the University of Birmingham. Using chemical biomarkers released by the brain immediately after a head injury occurs, researchers are able to pinpoint when patients need urgent medical attention. This saves time in delivering vital treatment and avoids […]
Today, Medilink member the University of Birmingham shares the amazing news, its spinout company Neuronostics has been awarded £720,000 of government funding to fund the development of its first prototype clinical platform – developing the software that will bring BioEP technology safely and securely into the clinic.
Established in 2014 by Cancer Research Technologies and Medilink member, the University of Birmingham, Birmingham spinout Revitope Oncology Inc has announced a research collaboration and license agreement with leading Chinese biopharmaceutical company Junshi Biosciences to develop precision cancer therapies that harness the body’s immune response to kill cancer cells while leaving healthy body tissues untouched.
On behalf of the University of Birmingham we would like to invite you to take part in a survey to identify current challenges in regulatory science in healthcare. The aim of the survey is to identify strategic areas for the development of regulatory standards, establish current and future training needs and identify the infrastructure required to support this.